NAFLD in type 2 diabetes mellitus: Still many challenging questions-Reference-Cited by-同舟云学术

NAFLD in type 2 diabetes mellitus: Still many challenging questions

Published:2020-08-18 Issue:2 Volume:37 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Cernea Simona¹²^ORCID,Raz Itamar³^ORCID

Affiliation:

1. Department M4/Internal Medicine IV George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş Târgu Mureş Romania

2. Diabetes, Nutrition and Metabolic Diseases Outpatient Unit Emergency County Clinical Hospital Târgu Mureş Romania

3. Diabetes Unit Hadassah Hebrew University Hospital Jerusalem Israel

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3386

Reference163 articles.

1. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

2. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes

3. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

4. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action

5. Type 2 diabetes mellitus and non‐alcoholic fatty liver disease: a systematic review and meta‐analysis;Amiri Dash Atan N;Gastroenterol Hepatol Bed Bench,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of cardiovascular risk factors in diabetic and nondiabetic patients with nonalcoholic fatty liver disease;Journal of Research in Medical Sciences;2024-08

2. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay;Life;2024-02-18

3. Advancements in Diagnostic and Therapeutic Interventions of Non-alcoholic Fatty Liver Disease: A Literature Review;Cureus;2023-09-08

4. Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study;Pharmaceuticals;2023-08-22

5. Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis;Diabetes/Metabolism Research and Reviews;2023-03-09